You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Smoldering Multiple Myeloma
  • Rochester, New York
    University of Rochester
2021-07-07
Jul 7, 2021
C
Active, not recruiting
  • Smoldering Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
2021-08-11
Aug 11, 2021
D
Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-02-01
Feb 1, 2021
O
Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
2021-10-18
Oct 18, 2021
I
Terminated
  • High Risk Smoldering Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2020-11-18
Nov 18, 2020
D
Suspended
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-02-01
Feb 1, 2021
N
Active, not recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-22
Oct 22, 2021
M
Recruiting
  • Smoldering Plasma Cell Myeloma
  • Biopsy Specimen Radiography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-12
Nov 12, 2021
N
Not yet recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
D
Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Multiple Myeloma
  • Metformin XR
  • Placebo
  • Boston, Massachusetts
  • +1 more
2021-08-18
Aug 18, 2021
D
Active, not recruiting
  • Smoldering Myeloma
  • Smoldering Multiple Myeloma
  • Denver, Colorado
  • +8 more
2021-11-01
Nov 1, 2021
U
Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Curcumin plus Piperine
  • Rochester, New York
    University of Rochester
2021-11-02
Nov 2, 2021
D
Active, not recruiting
  • Monoclonal Gammopathy
  • Smoldering Multiple Myeloma
  • Monterey, California
  • +5 more
2021-11-01
Nov 1, 2021
M
Active, not recruiting
  • Smoldering Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2020-11-23
Nov 23, 2020
M
Not yet recruiting
  • Myeloma
  • Belantamab mafodotin
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-22
Nov 22, 2021
H
Recruiting
  • Multiple Myeloma
  • +3 more
  • Questionnaire
  • Lehi, Utah
    HealthTree.org (Online)
2021-08-02
Aug 2, 2021
M
Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Multiple Myeloma
  • Plant based meals
  • Basking Ridge, New Jersey
  • +6 more
2021-06-04
Jun 4, 2021
M
Recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
2021-02-22
Feb 22, 2021
M
Recruiting
  • Smoldering Plasma Cell Myeloma
  • Isatuximab
  • Laboratory Biomarker Analysis
  • New York, New York
  • +2 more
2021-11-30
Nov 30, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • High Risk Smoldering Multiple Myeloma
  • Basking Ridge, New Jersey
  • +5 more
2021-11-15
Nov 15, 2021
D
Active, not recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    2021-02-01
    Feb 1, 2021
    I
    Recruiting
    • Smoldering Multiple Myeloma
    • Tampa, Florida
    • +9 more
    2021-05-25
    May 25, 2021
    N
    Terminated
    • Smoldering Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-03-04
      Mar 4, 2021
      M
      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Smoldering Plasma Cell Myeloma
      • Quality-of-Life Assessment
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      2021-11-23
      Nov 23, 2021